| SC 13G | 2014-07-10 | FMR LLC | Lion Biotechnologies, Inc. | 2,311,793 | 10.3% | EDGAR |
| SC 13D/A | 2014-02-20 | BRISTOL INVESTMENT FUND LTD | Lion Biotechnologies, Inc. | 3,998,732 | 21.2% | EDGAR |
| SC 13G/A | 2014-02-10 | ALPHA CAPITAL ANSTALT | Lion Biotechnologies, Inc. | 975,000 | 4.6% | EDGAR |
| SC 13G | 2014-01-02 | ALPHA CAPITAL ANSTALT | Lion Biotechnologies, Inc. | 1,400,000 | 7.2% | EDGAR |
| SC 13D/A | 2013-08-07 | BRISTOL INVESTMENT FUND LTD | Genesis Biopharma, Inc | 399,873,215 | 26.5% | EDGAR |
| SC 13G | 2013-06-03 | Ayer Capital Management, LP | Genesis Biopharma, Inc | 560,401,150 | 40.5% | EDGAR |
| SC 13D/A | 2013-05-31 | BRISTOL INVESTMENT FUND LTD | Genesis Biopharma, Inc | 399,873,215 | 29.1% | EDGAR |
| SC 13D | 2013-01-09 | BRISTOL INVESTMENT FUND LTD | Genesis Biopharma, Inc | 10,023,628 | 12.7% | EDGAR |
| SC 13G/A | 2012-06-08 | BRISTOL INVESTMENT FUND LTD | Genesis Biopharma, Inc | 10,013,628 | 12.8% | EDGAR |
| SC 13G/A | 2012-04-04 | Ayer Capital Management, LP | Genesis Biopharma, Inc | 2,400,000 | 3.0% | EDGAR |
| SC 13G/A | 2012-02-15 | BRISTOL INVESTMENT FUND LTD | Genesis Biopharma, Inc | 6,947,794 | 8.8% | EDGAR |
| SC 13G | 2011-10-21 | Ayer Capital Management, LP | Genesis Biopharma, Inc | 4,800,000 | 5.2% | EDGAR |
| SC 13D/A | 2011-05-12 | Brooke Robert T. | Genesis Biopharma, Inc | 4,440,008 | 6.0% | EDGAR |
| SC 13G | 2011-02-10 | Theorem Group, LLC | Genesis Biopharma, Inc | 6,440,841 | 8.8% | EDGAR |
| SC 13G | 2010-12-20 | Batavia Holdings Ltd | Genesis Biopharma, Inc | 5,854,753 | 8.0% | EDGAR |
| SC 13D/A | 2010-11-05 | Hamilton Atlantic | Genesis Biopharma, Inc | 0 | 0.0% | EDGAR |
| SC 13G | 2010-11-05 | BRISTOL INVESTMENT FUND LTD | Genesis Biopharma, Inc | 7,108,094 | 9.7% | EDGAR |
| SC 13D | 2010-03-29 | Hamilton Atlantic | Genesis Biopharma, Inc | 20,960,016 | 29.2% | EDGAR |
| SC 13D | 2010-03-24 | Brooke Robert T. | Genesis Biopharma, Inc | 5,940,008 | 8.3% | EDGAR |